Viking Therapeutics: Too Much Excitement Around Oral VK2735, Even If It Met High Expectations
Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...
Viking Therapeutics (VKTX) Gets a Buy from Truist Financial
Truist Financial analyst Joon Lee assigned a Buy rating to the stock today. The company’s shares closed last Friday at $72.88. Lee covers ...
Obesity pill data signal competition and hit drugmaker shares
Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly ...
How does Viking's weight loss med compare to ones from Novo, Eli Lilly?
Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...
bovnews8d
What’s Causing Viking Therapeutics Inc (VKTX) Stock’s 5.01% Jump Over the Last Six Months?
On Friday, Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $78.03 which represents a slight increase of $4.81 or 6.57% from the prior close of $73.22. The stock opened at ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript October 23, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
Q3 2024 Viking Therapeutics Inc Earnings Call
Welcome to the Viking Therapeutics third-quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded today, October 23, 2024. And I would ...
bovnews5d
Why Viking Therapeutics Inc (VKTX) Stock is Currently 7.51% Above from Its 20-Day SMA?
On Wednesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $71.75 which represents a decrease of $-1.60 or -2.18% from the prior close of $73.35. The stock opened at $71 and ...